transient ischemic attack (TIA) emergency department (ED) encounters with incomplete neurovascular imaging were associated with higher odds of subsequent stroke within 90 days.

Vincent M. Timpone, MD 


June 9, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), transient ischemic attack (TIA) emergency department (ED) encounters with incomplete neurovascular imaging were associated with higher odds of subsequent stroke within 90 days. 

“Increased access to urgent neurovascular imaging in patients with TIA may represent a target that could facilitate detection and treatment of modifiable stroke risk factors,” wrote first author Vincent M. Timpone, MD, from the department of radiology at the University of Colorado Hospital in Aurora

Timpone et al. studied data from the 2016–2017 Medicare Standard Analytical Files, which contain 100% sample claims for Medicare beneficiaries. Information was extracted via ICD-10 and CPT codes. Patients discharged from an ED encounter with a TIA diagnosis—who also underwent brain CT or brain MRI during or within 2 days of said encounter—were then identified. Patients were deemed to have complete neurovascular imaging if undergoing cross-sectional vascular imaging of both the brain (brain CTA or MRA) and neck (neck CTA or MRA or carotid ultrasound) during or within 2 days of their encounter. 

Ultimately, a total of 37.3% (69,825/111,417) of TIA ED encounters nationally showed associations with a complete neurovascular imaging workup. Adjusting for patient and hospital characteristics, an incomplete neurovascular imaging workup was associated with increased likelihood of stroke within 90 days of the encounter (OR 1.3 [95% CI: 1.23-1.38]). 

“To ensure that risk factors for stroke can be identified and treated,” the authors of this AJR accepted manuscript reiterated, “patients with TIA should have improved access to timely neurovascular imaging.” 

For more information: www.arrs.org 


Related Content

News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Radiology Imaging

July 23, 2024 — EMVision, an Australian medical device company focused on the development and commercialization of ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 22, 2024 — Healthcare artificial intelligence (AI) systems provider, Qure.ai, has announced its receipt of a Class ...

Time July 22, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 12, 2024
arrow
Subscribe Now